0001096906-25-000679.txt : 20250505 0001096906-25-000679.hdr.sgml : 20250505 20250505165745 ACCESSION NUMBER: 0001096906-25-000679 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250502 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 25913850 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utmd-20250502.htm UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING UTAH MEDICAL PRODUCTS, INC. - Form 8-K SEC filing
0000706698 false 0000706698 2025-05-02 2025-05-02

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

 

Date of Report (date of earliest event reported): May 2, 2025

 

 Commission File No. 001-12575

 

UTAH MEDICAL PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

                  UTAH                  

 

 

 

   87-0342734   

(State or other jurisdiction of

 

 

 

(IRS Employer

incorporation or organization)

 

 

 

Identification No.)

 

 

 

 

 

7043 South 300 West

Midvale, Utah  84047

(Address of principal executive offices)

 

 

 

Registrant’s telephone number:

 

(801) 566-1200

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

 

 

On May 2, 2025 at the Company’s annual meeting of stockholders, stockholders approved, did not approve or indicated their preference on the following matters submitted to them for consideration:

 

 

Elected Carrie Leigh as a director of the Company: 

For 665,574Withheld1,762,500Broker Non-Votes 732,568 

 

Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2025: 

For 3,148,121Against10,548Abstentions 1,973 

 

Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: 

For 2,383,762Against  39,327Abstentions 4,985     Broker Non-Votes 732,568 

 

 

Per Company policy, Ms. Leigh tendered her resignation, which was conditioned upon acceptance by the Board of Directors. The Board of Directors voted to not accept her resignation. Per Utah law, Ms. Leigh was elected to serve a three-year term and until her successor is elected and qualified.

 

The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials.  Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 

 

UTAH MEDICAL PRODUCTS, INC. 

REGISTRANT 

 

 

Date:        5/02/2025                   By:     /s/ Kevin L. Cornwell                          

    Kevin L. Cornwell 

    Chairman & CEO 

 EX-101.DEF 2 utmd-20250502_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 3 utmd-20250502_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Entity Address, State or Province Entity Address, Address Line One Voluntary filer Registrant Name Emerging Growth Company Fiscal Year End Pre-commencement Tender Offer Public Float SEC Form Local Phone Number Amendment Description Filer Category Soliciting Material Shell Company Ex Transition Period Period End date Registrant CIK Small Business Well-known Seasoned Issuer Details Entity Address, City or Town Current with reporting Entity Address, Postal Zip Code Trading Symbol Securities Act File Number Interactive Data Current Number of common stock shares outstanding Tax Identification Number (TIN) Written Communications Trading Exchange Amendment Flag Entity Incorporation, State or Country Code City Area Code EX-101.PRE 4 utmd-20250502_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 5 utmd-20250502.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink XML 7 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Document and Entity Information
May 02, 2025
Details  
Registrant CIK 0000706698
Registrant Name UTAH MEDICAL PRODUCTS, INC.
SEC Form 8-K
Period End date May 02, 2025
Tax Identification Number (TIN) 87-0342734
Emerging Growth Company false
Securities Act File Number 001-12575
Entity Incorporation, State or Country Code UT
Entity Address, Address Line One 7043 South 300 West
Entity Address, City or Town Midvale
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84047
City Area Code 801
Local Phone Number 566-1200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X9 M9K>]9!:GE6APX9>H_ 0 / ( \ !X;"]W M;W)K8F]O:RYX;6R-49:EL@9OTDUL(,BDBN0- M2TN'+#4$QJ8:@+W+IGD^R[S!H)>+D6M#V743&4K&& 3L@!W".?W.NU:=,.$> M'?)WH?NW ZT\!O1X 5OH7*M4Q_-+)+S$P,9M2XK.%7HR#'9 C.4?>-N)_#3[ MU"-L]A]&A!1ZE@MAA92XW^CYC6@\@2P/73>TFH M=>Y!L/?P&HT=S8\?M_P!4$L#!!0 ( #:'I5HD'INBK0 /@! : M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q= M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*'3^ 5!+ P04 " VAZ5:99!YDAD! #/ P M$P %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M= M< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4' M3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!- MFI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXP MC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T, M:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0 ( M #:'I5I&QTU(E0 ,T 0 " 0 !D;V-0&UL4$L! A0#% @ -H>E6L$4!ECO *P( !$ M ( !PP &1O8U!R;W!S+V-O&UL4$L! A0#% @ -H>E6IE#@ & @($B" M>&PO=V]R:W-H965T&UL4$L! A0#% @ -H>E6I^@&_"Q M @ X@P T ( !10P 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ -H>E6B0>FZ*M M^ $ !H ( !=A$ 'AL+U]R96QS+W=OE6F60>9(9 0 SP, !, ( ! M6Q( %M#;VYT96YT7U1Y<&5S72YX;6Q02P4& D "0 ^ @ I1, end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 1 19 1 false 0 0 false 0 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports utmd-20250502.htm utmd-20250502.xsd utmd-20250502_def.xml utmd-20250502_lab.xml utmd-20250502_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "utmd-20250502.htm": { "nsprefix": "fil", "nsuri": "http://utahmed.com/20250502", "dts": { "inline": { "local": [ "utmd-20250502.htm" ] }, "schema": { "local": [ "utmd-20250502.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "utmd-20250502_def.xml" ] }, "labelLink": { "local": [ "utmd-20250502_lab.xml" ] }, "presentationLink": { "local": [ "utmd-20250502_pre.xml" ] } }, "keyStandard": 19, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 34, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 19 }, "report": { "R1": { "role": "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation", "longName": "000010 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "D250502", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "utmd-20250502.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "D250502", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "utmd-20250502.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Fiscal Year End", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Period End date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "SEC Form", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Registrant CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Number of common stock shares outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current with reporting", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r0" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r0" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r5" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r0" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r0" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Tax Identification Number (TIN)", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r0" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Voluntary filer", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r6" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Exchange", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "us-gaap_TextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TextBlockAbstract", "lang": { "en-us": { "role": { "label": "Details" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://utahmed.com/20250502/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r7" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001096906-25-000679-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001096906-25-000679-xbrl.zip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utmd-20250502_htm.xml IDEA: XBRL DOCUMENT 0000706698 2025-05-02 2025-05-02 0000706698 false 8-K 2025-05-02 001-12575 UTAH MEDICAL PRODUCTS, INC. UT 87-0342734 7043 South 300 West Midvale UT 84047 801 566-1200 false false false false false